date,title,source
Oct-22-18,Is a Beat in Store for Vertex (VRTX) This Earnings Season?,Zacks
Oct-24-18,Vertex Pharmaceuticals Inc (VRTX) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-26-18,3 Stocks to Buy and Hold for the Next 50 Years,Motley Fool
Oct-29-18,Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2,Zacks
Oct-30-18,Is a Beat in Store for CRISPR (CRSP) This Earnings Season?,Zacks
Oct-31-18,Is a Beat in Store for Editas (EDIT) This Earnings Season?,Zacks
Nov-01-18,"Ophthotech (OPHT) Q3 Earnings Beat, Gene Therapy in Focus",Zacks
Nov-05-18,Here's Why CRISPR Stocks Fell as Much as 40.7% in October,Motley Fool
Nov-05-18,"ImmunoGen (IMGN) Beats on Earnings in Q3, Lowers Guidance",Zacks
Nov-05-18,5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings,Zacks
Nov-07-18,Cambridge's Editas asks FDA to start gene editing trial,American City Business Journals
Nov-07-18,CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-09-18,CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology,GlobeNewswire
Nov-12-18,CRISPR Therapeutics AG (CRSP) Stock Moves -0.55%: What You Should Know,Zacks
Nov-12-18,3 DNA Stocks That Are on the Uptrend,InvestorPlace
Nov-13-18,"New Research Coverage Highlights CAS Medical, Saia, Core Laboratories N.V, Perceptron, CRISPR Therapeutics AG, and IEC Electronics  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-21-18,CRISPR Therapeutics to Participate in Upcoming Investor Conferences,GlobeNewswire
Nov-26-18,"With genetically edited babies, a scientist transgresses a moral boundary",MarketWatch
Nov-26-18,Mass. biotech leaders voice alarm over report of first gene-edited babies,American City Business Journals
Nov-30-18,CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know,Zacks
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Why Crispr Therapeutics Stock Is Up By 65% So Far in 2018,Motley Fool
Dec-10-18,Here's Why Crispr Therapeutics Rose 17% in November,Motley Fool
Dec-10-18,Here's Why Editas Medicine Jumped 23% in November,Motley Fool
Dec-13-18,3 High-Growth Stocks That Are Just Getting Started,Motley Fool
Dec-13-18,Top 10 Healthcare Stories of 2018,Motley Fool
Dec-18-18,Gene-Editing Stocks Took Stutter Steps Forward in 2018,Motley Fool
Dec-18-18,Under Armour Tanks on Guidance,Motley Fool
Dec-19-18,Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint,Zacks
Dec-19-18,Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't,American City Business Journals
Dec-21-18,Did Chinas Designer Babies Just Open Pandoras Box?,Motley Fool
Dec-24-18,Don't Miss Chinese Biotechs,Motley Fool
Dec-27-18,3 Gene Therapy Stocks to Play Biotechs Future,InvestorPlace
Dec-27-18,Christmas Comes a Day Late,Zacks
Dec-31-18,Dow Rises 91 Points Because Everybodys Ready for a New Year,Barrons.com
Jan-03-19,Vertex teams up with Feng Zhang startup on gene editing tech,American City Business Journals
